Do you have the same question? Follow this Question
Nov 24, 2025 - 12:44 PM
We’ve provided several answers to questions related to Nubeqa (Darolutamide) , see some other helpful Q&A related to this product.
Question: Is this medication safe to use during pregnancy?
Answer: No, it is contraindicated in pregnancy because it can harm the fetus. This information is critical for women of reproductive age and men with partners who could become pregnant, ensuring safety for unborn children.
Question: What is the KEGG code for this medication?
Answer: The KEGG code is D11021. KEGG (Kyoto Encyclopedia of Genes and Genomes) codes are valuable for understanding the drug's interactions within biological pathways.
Question: What is the legal status of this medication?
Answer: It is available by prescription only (Rx-only). Prescription status ensures that the medication is used under medical supervision, which is crucial for safety in cancer treatment.
Question: What is the protein binding of the main metabolite?
Answer: The main metabolite is 99.8% protein bound. High protein binding of metabolites can influence both efficacy and safety, which is important for patient monitoring.
Question: How should this medication be taken?
Answer: It should be swallowed whole with food twice daily; do not crush, break, or chew the tablets. Taking the medication as directed ensures proper absorption and reduces the risk of adverse effects.
